FDA's scientific base eroded, report says

The US linkurl:Food and Drug Administration;http://www.the-scientist.com/article/display/36885 suffers from "serious scientific deficiencies," potentially compromising the agency's ability to protect the health and safety of consumers, a linkurl:report;http://tinyurl.com/yvnk28 by the FDA's science board has concluded. The agency has had the most trouble regulating areas such as linkurl:systems biology,;http://www.the-scientist.com/article/display/53421 nanotechnology, and linkurl:regenerative m

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The US linkurl:Food and Drug Administration;http://www.the-scientist.com/article/display/36885 suffers from "serious scientific deficiencies," potentially compromising the agency's ability to protect the health and safety of consumers, a linkurl:report;http://tinyurl.com/yvnk28 by the FDA's science board has concluded. The agency has had the most trouble regulating areas such as linkurl:systems biology,;http://www.the-scientist.com/article/display/53421 nanotechnology, and linkurl:regenerative medicine.;http://www.the-scientist.com/article/display/53224 The report, commissioned by the FDA's commissioner linkurl:Andrew von Eschenbach;http://www.the-scientist.com/news/display/37416/ and released last week, states in bold font: "The FDA cannot fulfill its mission because its scientific base has eroded and its scientific organizational structure is weak." The cause, according to the report, is a linkurl:lack of financial support,;http://www.the-scientist.com/news/display/52917 inadequate information technology, and too few staff members. The __New York Times__ today linkurl:got no more comment;http://tinyurl.com/2bj5np from the FDA than that the agency "values the evaluation." To solve the "crisis" at the FDA, the board recommends better infrastructure for sharing data, more external collaborations, better staff recruitment, and, of course, more funding. The FDA is holding a public science board advisory committee linkurl:meeting today;http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-20550.pdf (December 3) at the Office of the Commissioner in Rockville, MD.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA